[1] |
宋瑞, 吕琳, 谭嘉禾, 等. 利什曼病合并噬血综合征1例[J]. 现代医药卫生, 2020, 36(12):1942-1944.
|
|
Song R, Lv L, Tan JH, et al. Leishmaniasis complicated with hemophagocytic syndrome: a case report[J]. J Mod Med & Health, 2020, 36(12):1942-1944
|
[2] |
张鸿娟, 黄本林, 杨雪婷, 等. 1例内脏利什曼病死亡病例诊治体会[J]. 检验医学, 2020, 35(10):1083-1086.
|
|
Zhang HJ, Huang BL, Yang XT. Diagnosis and treatment experience of 1 case of visceral leishmaniasis death[J]. Lab Med, 2020, 35(10):1083-1086.
|
[3] |
袁宏, 唐红, 张跃新. 中国利什曼原虫感染诊断和治疗专家共识[J]. 中华传染病杂志, 2017, 35(9):513-518.
|
|
Yuan H, Tang H, Zhang YX. Expert consensus on diagnosis and treatment of Leishmania sinensis infection in China[J]. Chin J Infect Med, 2017, 35(9):513-518.
|
[4] |
唐雪梅, 赵晓东. 噬血细胞综合征遗传特点与免疫发病机制[J]. 中国实用儿科杂志, 2012, 27(10):744-747.
|
|
Tang XM, Zhao XD. Genetic characteristics and immune pathogenesis of hemophagocytic syndrome[J]. Chinese Journal of Practical Pediatrics, 2012, 27(10):744-747.
|
[5] |
李红, 赵亚楠, 赵丽琴, 等. 山西省1例再发内脏利什曼病患者诊治体会[J]. 中华地方病学杂志, 2019(3):247-248.
|
|
Li H, Zhao YN, Zhao LQ, et al. Diagnosis and treatment experience of a patient with recurrent visceral leishmaniasis in Shanxi Province[J]. Chinese Journal of Endemiology, 2019(3):247-248
|
[6] |
Henter JI, M Aricò, Egeler R M, et al. HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis[J]. Med Pediatr Oncol, 1997, 28(5):342-347.
pmid: 9121398
|
|
Henter J I, M Aricò, Egeler R M, et al. HLH-94: 噬血细胞性淋巴组织细胞增多症的治疗方案. 组织细胞学会HLH研究小组. 医学儿科杂志, 1997, 28(5):342-347.
pmid: 9121398
|
[7] |
郑玉华, 白永飞, 帖萍, 等. 2010-2019年山西省人群内脏利什曼病流行特征分析[J]. 中国寄生虫学与寄生虫病杂志, 2021, 39(3):352-358.
|
|
Zheng YH, Bai YF, Tie P, et al. Epidemiological characteristics of visceral leishmaniasis in shanxi population from 2010 to 2019[J]. Chinese Journal of Parasitology and Parasitic Diseases, 2021, 39(3):352-358.
|
[8] |
管立人, 高春花. 利什曼病及其防治[J]. 中国寄生虫学与寄生虫病杂志, 2018, 36(4):418-424,428.
|
|
Guan LR, Gao CH. Leishmaniasis and its control[J]. Chinese Journal of Parasitology and Parasitic Diseases, 2018, 36(04):418-424+428.
|
[9] |
赵彤, 刘永清, 张健, 等. 1例输入性黑热病病例的调查[J]. 预防医学论坛, 2020, 26(1):74-75.
|
|
Zhao T, Liu YQ, Zhang J, et al. Investigation of 1 case of imported kala-azar[J]. Prevent Med Tri, 2020, 26(1):74-75.
|
[10] |
凌攀, 王晓凤, 赵仪, 等. 2015-2019年四川省疾控黑热病病例流行特征分析[J]. 解放军预防医学杂志, 2020, 38(4):63-65.
|
|
Ling P, Wang XF, Zhao Y, et al. Epidemiological characteristics of disease-controlled black fever cases in Sichuan Province, 2015-2019[J]. PLA Journal of Preventive Medicine, 2020, 38(4):63-65.
|
[11] |
World Health Organization. Report of a meeting of the WHO Expert Committee on the Control of Leishmaniases[R]. Geneva, Switzerland, 2010.
|
[12] |
中华医学会儿科学分会血液学组. 噬血细胞性淋巴组织细胞增生症诊疗建议[J]. 中华儿科杂志, 2012, 50(11):821-825.
|
|
Hematology Group of Science Branch of Chinese Medical Association. Recommendations for the diagnosis and treatment of hemophagocytic lymphohistoplasia[J]. Chinese Journal of Pediatrics, 2012, 50(11): 821-825.
|
[13] |
康艳. 骨髓检查确诊黑热病3例[J]. 临床医药文献电子杂志, 2020, 7(23):174,194.
|
|
Kang Y. Bone marrow examination confirmed 3 cases of kala-azar[J]. Electronic Journal of Clinical Medical Literature, 2020, 7(23):174,194.
|
[14] |
叶梅, 魏立. 疑难黑热病诊治1例体会并文献复习[J]. 临床医药文献电子杂志, 2020, 7(5):1,3.
|
|
Ye M, Wei L. Diagnosis and treatment of difficult black fever in a case and literature review[J]. Electronic Journal of Clinical Medical Literature, 2020, 7(5):1,3.
|